Anzahl der Publikationen: 13
Zeitschriftenartikel
Schmid, P.; Cortes, J.; Dent, R.; Pusztai, L.; McArthur, H.; Kummel, S.; Bergh, J.; Denkert, C.; Park, Y. H.; Hui, R.; Harbeck, N.; Takahashi, M.; Untch, M.; Fasching, P. A.; Cardoso, F.; Andersen, J.; Patt, D.; Danso, M.; Ferreira, M.; Mouret-Reynier, M.-A.; Im, S.-A.; Ahn, J.-H.; Gion, M.; Baron-Hay, S.; Boileau, J.-F.; Ding, Y.; Tryfonidis, K.; Aktan, G.; Karantza, V. und O'Shaughnessy, J.
(2022):
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
In: New England Journal of Medicine, Bd. 386, Nr. 6: S. 556-567
Möbus, V.; Jackisch, C.; Luck, H. J.; du Bois, A.; Thomssen, C.; Kuhn, W.; Nitz, U.; Schneeweiss, A.; Huober, J.; Harbeck, N.; Minckwitz, G. von; Runnebaum, I. B.; Hinke, A.; Konecny, G. E.; Untch, M. und Kurbacher, C.
(2018):
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
In: Annals of Oncology, Bd. 29, Nr. 1: S. 178-185
Mackelenberg, M. van; Denkert, C.; Nekljudova, V.; Karn, T.; Schem, C.; Marme, F.; Stickeler, E.; Jackisch, C.; Hanusch, C.; Huober, J.; Fasching, P.; Blohmer, J.-U.; Kummel, S.; Müller, V.; Schneeweiss, A.; Untch, M.; Minckwitz, G. von; Weber, K. und Loibl, S.
(2017):
Outcome after neoadjuvant chemotherapy in progesterone receptor negative breast cancer patients - A pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
In: Cancer Research, Bd. 77
Hadji, P.; Coleman, R. E.; Wilson, C.; Powles, T. J.; Clezardin, P.; Aapro, M.; Costa, L.; Body, J.-J.; Markopoulos, C.; Santini, D.; Diel, I.; Di Leo, A.; Cameron, D.; Dodwell, D.; Smith, I.; Gnant, M.; Gray, R.; Harbeck, N.; Thurlimann, B.; Untch, M.; Cortes, J.; Martin, M.; Albert, U.-S.; Conte, P.-F.; Ejlertsen, B.; Bergh, J.; Kaufmann, M. und Holen, I.
(2016):
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
In: Annals of Oncology, Bd. 27, Nr. 3: S. 379-390
Fasching, P. A.; Loibl, S.; Eidtmann, H.; Tesch, H.; Untch, M.; Hilfrich, J.; Schem, C.; Rezai, M.; Gerber, B.; Costa, S. D.; Blohmer, J. U.; Fehm, T. N.; Huober, J.; Liedtke, C.; Müller, V.; Nekljudova, V.; Weber, K.; Rack, B.; Rübner, M.; Wang, L.; Ingle, J. N.; Weinshilboum, R. M.; Minckwitz, G. von und Couch, F.
(2016):
BRCA mutations, therapy response and prognosis in the neoadjuvant GeparQuinto study.
In: Cancer Research, Bd. 76
Untch, M.; Augustin, D.; Ettl, J.; Haidinger, R.; Harbeck, N.; Lück, H.-J.; Lüftner, D.; Marée, F.; Müller, L.; Overkamp, F.; Ruckhäberle, E.; Thill, M.; Thomssen, C.; Wuerstlein, R. und Marschner, N.
(2016):
ABC3 Consensus Commented from the Perspective of the German Guidelines Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07.11.2015.
In: Geburtshilfe und Frauenheilkunde, Bd. 76, Nr. 2: S. 156-163
Janning, M.; Müller, V; Vettorazzi, E.; Cubas-Cordova, M.; Gensch, V; Ben Batalla, I; Eulenburg, C. zu; Schem, C.; Fasching, P. A.; Schnappauf, B.; Karn, T.; Fehm, T.; Just, M.; Kühn, T.; Holms, F.; Overkamp, F.; Krabisch, P.; Rack, B.; Denkert, C.; Untch, M.; Tesch, H.; Rezai, M.; Kittel, K.; Pantel, K.; Bokemeyer, C.; Loibl, S.; Minckwitz, G. von und Loges, S.
(2016):
Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial.
In: Oncology Research and Treatment, Bd. 39: S. 185
Lebeau, A.; Turzynski, A.; Braun, S.; Behrhof, W.; Fleige, B.; Schmitt, W. D.; Grob, T. J.; Burkhardt, L.; Hölzel, Dieter; Jackisch, C.; Thomssen, C.; Muller, V. und Untch, M.
(2010):
Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.
In: Journal of Clinical Oncology, Bd. 28, Nr. 20: S. 3264-3270
Hermelink, K.; Henschel, Volkmar; Untch, M.; Bauerfeind, I.; Lux, M. P. und Munzel, K.
(2008):
Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
In: Cancer, Bd. 113, Nr. 9: S. 2431-2439
Diese Liste wurde am
Sun Aug 11 00:00:53 2024 CEST
erstellt.